Aardvark Therapeutics stock tumbles on FDA clinical hold, analyst downgrades

Investing.com Gold reports: Aardvark Therapeutics stock tumbles on FDA clinical hold, analyst downgrades. Full body text was unavailable at ingest time, so this brief is based on headline context.